NORTHERN TRUST CORP - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,213,204
+26.6%
538,023
+16.9%
0.01%
+25.0%
Q2 2023$21,497,430
+57.1%
460,429
+28.7%
0.00%
+33.3%
Q1 2023$13,688,165
-30.7%
357,767
-0.7%
0.00%
-25.0%
Q4 2022$19,743,180
+119.2%
360,277
+36.2%
0.00%
+100.0%
Q3 2022$9,007,000
+290.1%
264,510
+8.3%
0.00%
Q2 2022$2,309,000
-31.0%
244,278
+3.5%
0.00%
-100.0%
Q1 2022$3,347,000
-36.6%
235,925
-5.5%
0.00%0.0%
Q4 2021$5,283,000
-4.3%
249,774
+1.1%
0.00%0.0%
Q3 2021$5,520,000
-13.4%
246,943
-3.9%
0.00%0.0%
Q2 2021$6,376,000
+26.3%
257,012
+47.7%
0.00%0.0%
Q1 2021$5,047,000
+4.6%
174,000
-6.9%
0.00%0.0%
Q4 2020$4,823,000
-18.4%
186,968
-2.7%
0.00%0.0%
Q3 2020$5,914,000
+54.1%
192,084
+24.7%
0.00%0.0%
Q2 2020$3,839,000
+81.3%
154,052
+54.3%
0.00%0.0%
Q1 2020$2,117,000
+37.9%
99,862
+44.4%
0.00%
Q4 2019$1,535,000
-3.5%
69,161
-1.1%
0.00%
Q3 2019$1,590,000
+632.7%
69,936
+517.4%
0.00%
Q2 2019$217,00011,3280.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders